O'Dell v. Intercept Pharmaceuticals et al
ORDER Accordingly, any interested attorneys shall file requests to be appointed lead counsel by November 29, 2023. Opposition to any such application shall be filed by December 6, 2023. SO ORDERED. (Motions due by 11/29/2023., Responses due by 12/6/2023) (Signed by Judge Analisa Torres on 11/15/2023) (jca)
UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK
DATE FILED: 11/15/2023
-againstINTERCEPT PHARMACEUTICALS, INC.,
JEROME DURSO, PAOLO FUNDARO,
MARK PRUZANSKI, SRINIVAS
AKKARAJU, LUCA BENATTI, DANIEL
BRADBURY, KEITH GOTTESDIENER,
NANCY MILLER-RICH, DAGMAR ROSABJORKESON, GINO SANTINI, and GLENN
23 Civ. 9052 (AT)
ANALISA TORRES, District Judge:
On November 2, 2023, the Court informed the parties that it intends to consolidate this
action with Dickerson v. Intercept Pharmaceuticals et al., No. 23 Civ. 9121, and directed any
interested attorneys to submit applications for appointment as lead counsel by November 10, 2023.
ECF No. 8. That deadline has now passed and the Court has received no applications.
Accordingly, any interested attorneys shall file requests to be appointed lead counsel by
November 29, 2023. Opposition to any such application shall be filed by December 6, 2023.
Dated: November 15, 2023
New York, New York
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?